Violation Tracker Individual Record

Company: 
Apotex Corp.
Penalty: 
$24,100,000
Year: 
2020
Date: 
May 7, 2020
Offense Group: 
competition-related offenses
Primary Offense: 
price-fixing or anti-competitive practices
Violation Description: 

Apotex Corp., a generic pharmaceutical company headquartered in Florida, agreed to pay a criminal penalty of $24.1 million under a deferred prosecution agreement relating to fixing the price of the generic drug pravastatin.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
Justice Department Antitrust Division
Civil or Criminal Case: 
criminal
Prosecution Agreement: 
deferred prosecution agreement
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.